Indication:All licensed indications
On the balance of their clinical and cost effectiveness neither beta
interferon nor glatiramer acetate is recommended for the treatment of
multiple sclerosis (MS) in the NHS in England and Wales.
Beta interferon and glatiramer acetate for the treatment of multiple sclerosis